financetom
Business
financetom
/
Business
/
Electronic Arts Likely to Keep FY25 Guidance Unchanged, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Electronic Arts Likely to Keep FY25 Guidance Unchanged, Oppenheimer Says
Jan 21, 2025 9:37 AM

12:06 PM EST, 01/21/2025 (MT Newswires) -- Electronic Arts ( EA ) is facing bearish investor sentiment ahead of its fiscal Q3 results amid a dwindling player base for Apex Legends and tepid sales for Dragon Age, which will keep the company from revising higher its fiscal 2025 guidance, Oppenheimer said Tuesday in a note.

The investment firm expects fiscal Q3 bookings of $2.51 billion and earnings per share of $3.43, largely in line with consensus estimates.

Oppenheimer trimmed its fiscal 2025 and 2026 bookings and EPS estimates for the video game developer, citing weakness in Apex Legends engagement, lower-than-expected full game sales of Dragon Age, and taking into account the release of Battlefield in Q4 of fiscal 2026.

The firm now projects bookings of $7.67 billion and EPS of $7.82 for fiscal 2025, down from its prior estimates of $7.7 billion and $7.86. For fiscal 2026, it now sees bookings of $8.09 billion and EPS of $8.53, down from $8.24 billion and $8.60.

Oppenheimer analysts said the key question is "how management will comment on FY26." Due to increased competition this year in the multiplayer shooter category and uncertainty in the release of Grand Theft Auto IV, the analysts said "the potential outcome for FY26 growth is wider than what we expected a quarter ago."

Oppenheimer maintained its outperform rating on the stock, and lowered the price target to $165 from $170.

EA shares were edging 0.5% higher in recent trading.

Price: 142.61, Change: +0.60, Percent Change: +0.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Underestimating Negative Impact of Autonomous Vehicles on Uber, Lyft, Wedbush Says
Market Underestimating Negative Impact of Autonomous Vehicles on Uber, Lyft, Wedbush Says
Sep 4, 2025
02:09 PM EDT, 09/04/2025 (MT Newswires) -- Shares of Uber Technologies ( UBER ) and Lyft ( LYFT ) were edging lower Thursday after Wedbush analysts said they continue to believe the market is underestimating a negative terminal value impact that autonomous vehicles could have on the companies' discounted cash flow value. Wedbush said Tesla's (TSLA) Robotaxi app is now...
Tyson Foods says it has succession plans after executive's shock departure
Tyson Foods says it has succession plans after executive's shock departure
Sep 4, 2025
CHICAGO (Reuters) -Tyson Foods sought to reassure investors that it has succession plans in place on Thursday, after announcing this week that an executive seen by some analysts as a possible future CEO left the company over conduct violations. The meatpacker said late on Tuesday that Chief Supply Chain Officer Brady Stewart, who has also overseen its beef, pork and...
Trump FTC takes first action against worker noncompete agreements
Trump FTC takes first action against worker noncompete agreements
Sep 4, 2025
(Reuters) -The U.S. Federal Trade Commission barred the largest pet cremation business in the U.S. from enforcing its noncompete agreements with 1,800 workers on Thursday, saying they unfairly diminish workers' leverage with their employer. The move shows how FTC Chair Andrew Ferguson is using enforcement actions against targeted instances of practices the agency says can harm workers and consumers, where...
US plans to bring Gilead HIV drug to market in high-burden HIV countries
US plans to bring Gilead HIV drug to market in high-burden HIV countries
Sep 4, 2025
WASHINGTON, Sept 4 (Reuters) - The U.S. State Department announced a plan on Thursday to bring Gilead Sciences Inc's ( GILD ) drug lenacapavir to market at cost in high-burden HIV countries in an effort to reach 2 million people over three years. The company will offer the long-acting HIV prevention drug to the Global Fund and the U.S. government's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved